Key result
DKK2 expression was significantly decreased in obesity cardiomyopathy, and its knockdown activated the β-catenin/Wnt3a pathway, suggesting DKK2 protects against obesity cardiomyopathy.
Why the study?
High-fat diet induces structural and functional cardiac disorders, but the underlying mechanism remains elusive.
Does DKK2 modulation affect high-fat diet-induced myocardial injury via the Wnt/β-catenin pathway in preclinical models?
Does DKK2 modulation affect high-fat diet-induced myocardial injury via the Wnt/β-catenin pathway in preclinical models?
Answers are grounded in this paper and cite their sources.
DKK2 protects against obesity-induced cardiomyopathy by inhibiting the Wnt/β-catenin pathway, highlighting a potential novel therapeutic target.
High-fat diet could induce structural and functional disorders of the heart, but the underlying mechanism remains elusive. This study aimed to explore related mechanism of obesity cardiomyopathy. Obesity model was established by feeding rats with a high-fat diet, and H9c2 cells were stimulated with palmitic acid to mimic high-fat stimulation. Whole transcriptome analysis results showed that the expression of Dickkopf-2 (DKK2) in obesity cardiomyopathy group was significantly lower than that in control group and simple obesity group. Overexpression and knockdown of DKK2 was achieved by infection with lentivirus. Weight, blood glucose, lipids, blood pressure, and insulin, HE staining, Sirius red staining and echocardiography results were analyzed in rats at 8 and 16 weeks after various interventions. qRT-PCR and western blots were used to detect the expression of RNAs and proteins. High-fat diet-induced obese rats presented with changes in serum lipid, insulin, and increases in myocardial inflammation and fibrosis. Protein and mRNA expression levels of DKK2 were significantly decreased in the obesity cardiomyopathy group compared with the obesity and control group. In vitro, knockdown of DKK2 activated β-catenin/Wnt3a pathway, while overexpress of DKK2 inhibited β-catenin/Wnt3a expression. Activating DKK2 may serve as a novel therapeutic intervention option for obesity cardiomyopathy and obesity-related metabolic disorders, and future studies are needed to validate this hypothesis. DKK2 protects obese cardiomyopathy by inhibiting Wnt/β-catenin pathway. • Based on the whole genome sequencing results, the current study verify the protective role of DKK2 in obesity cardiomyopathy. • DKK2 was proven to regulate the process of obesity induced cardiomyopathy via DKK2/Wnt/β-catenin signal pathway. • Activating DKK2 may serve as a novel option.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied Obesity cardiomyopathy. DKK2 overexpression and knockdown vs. Control and simple obesity groups was evaluated on DKK2 expression and myocardial inflammation/fibrosis. DKK2 expression was significantly decreased in obesity cardiomyopathy, and its knockdown activated the β-catenin/Wnt3a pathway, suggesting DKK2 protects against obesity cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: